Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

5.5 million and $11.0 million in the second quarter and first half of 2013, respectively.

Net loss in the second quarter of 2014 was $32.6 million or $0.26 loss per share as compared to $42.7 million or $0.37 loss per share in the second quarter of 2013. Net loss in the first half of 2014 was $78.8 million or $0.63 loss per share as compared to $97.8 million or $0.85 loss per share in the first half of 2013.

The company also announced upcoming presentations at the following medical meetings and scientific congresses during the third and fourth quarters of 2014:

Global Cancer Conference 2014, Hyderabad, India:

  • Oral Abstract Title: "NKTR-214: A long-acting, engineered immunotherapy shows excellent therapeutic efficacy in multiple syngeneic mouse tumor models both alone and in combination with checkpoint inhibition", Addepalli, M., et al. 
  • Date: September 15-17, 2014
  • IASP 15th World Congress on Pain, Buenos Aires, Argentina:

  • Abstract/Poster Title: "Multi-dimensional pathway analysis reveals unique pharmacological signatures of kappa opioid receptor agonists", Brew, C., et al. 
  • Date: October 10, 2014, 9:30 a.m. Argentina Time
  • Society for Neuroscience, Washington, DC:

  • Abstract/Poster Title: "SEO-16: An orally active opioid analgesic with rapid onset of activity and reduced CNS side effects", Harrison, S., et al. 
  • Poster Session 244: "Opioids and other analgesics"
  • Date: November 16, 2014, 1:00 p.m. — 5:00 p.m. Eastern Time
  • Conference Call to Discuss Second Quarter 2014 Financial ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time today, Thursday, July 31, 2014.

    This press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
    2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
    3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
    5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
    6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
    7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
    8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
    9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
    10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
    11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/30/2014)... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... serving the pharmaceutical, biotechnology, and medical device industries, with ... the United States , today announced the ... Tel Aviv area of Israel.  ... of integrated R&D services to local customers. It will ...
    (Date:10/30/2014)... 30, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, has recently released a ... is a topical liquid tetracycline-based antibiotic that uses ... convert oral medication active ingredients into topical drugs. ... aid antibiotic to help prevent skin infection in ...
    (Date:10/30/2014)... 2014 Molecular Profiles Ltd., a subsidiary of ... Maryland -based Xceleron have announced a ... clinical development that will be launched at AAPS in ... This partnership extends Molecular Profiles, new ROADMAP to ... this month. The company also has complementary collaborations in ...
    Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
    ... CINCINNATI, April 11, 2011 HealthWarehouse.com, Inc. (OTC: ... announced Consumer Reports found it to have among ... Lipitor, Nexium, Plavix, and Singulair. The ... rating pharmacies for price, accuracy, knowledge, and speed. ...
    ... TechniScan,s (OTC BB: TSNI) novel breast ultrasound technology ... Institute of Ultrasound Medicine,s annual conference in New York ... session on advanced breast ultrasound imaging, Michael Andre, Ph.D., ... of California, San Diego Moores Cancer Center that enlists ...
    Cached Medicine Technology:Consumer Reports Finds HealthWarehouse.com Has Lowest Total Price for Lipitor, Nexium, Plavix, and Singulair 2TechniScan's Breast Imaging Science Featured at National Ultrasound Conference 2TechniScan's Breast Imaging Science Featured at National Ultrasound Conference 3
    (Date:10/30/2014)... (PRWEB) October 30, 2014 Dr. Joseph Furlin ... new website for his practices; OB GYN in Melrose ... . This website contains important information about each of ... well as downloadable patient forms in English and Spanish. ... the service pages on the website provide Dr. Furlin’s patients ...
    (Date:10/30/2014)... (PRWEB) October 30, 2014 Global prebiotics ... 2020, according to a new study by Grand View ... surging demand for sugar and fat free products owing ... the demand for prebiotics over the forecast period. , ... , Food & beverage was the largest application ...
    (Date:10/30/2014)... 30, 2014 REV'D Provision Co. announced ... available through a unique service called, The Feed ... empower the everyday athlete. The Feed has taken the ... created a system to pass that information on to ... is now available on The Feed!” says REV’D® marketing ...
    (Date:10/30/2014)... York (PRWEB) October 30, 2014 The ... (NAMS) came to a close on Saturday, October ... since the Society’s inception in 1989. NAMS is North ... and quality of life of all women during midlife ... aging. With over 2,000 physicians and thought leaders from ...
    (Date:10/30/2014)... (PRWEB) October 30, 2014 Sound Telecom, a ... infographic that will assist people any time they wonder, “Should ... the right answer by leading them through a series of ... to their initial query. , There are many considerations and ... to use an answering service . This decision infographic ...
    Breaking Medicine News(10 mins):Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2
    ... ... at least one broken implant within 11 years. Smart Choice MRI offers the ... the first MRI clinic in Milwaukee to offer a silicone implant rupture screening ... to a 75% savings when compared to other MRI providers. , ...
    ... ... Dispensing System™ at ASCP as one option for addressing health reform’s new medication waste ... ... has surpassed 500 customers of its world-class software and proven hardware components to enhance ...
    ... mice, researchers found , WEDNESDAY, May 26 (HealthDay News) ... certain industrial chemicals while pregnant are at an increased ... animal study suggests. , The chemicals -- bisphenol-A (BPA) ... manufacturing purposes, and are known for interfering with hormonal ...
    ... 11 Thursday 15 July 2010, Stockholm, Sweden, Stockholm ... Excess body weight is a major risk factor for ... cancer, making obesity one of the leading preventable causes ... the most significant public health challenges of the 21st ...
    ... BEER-SHEVA, ISRAEL, May 26, 2010 -- A new study ... of the Negev (BGU) indicates that advanced age does ... that older drivers are more sensitive to potential hazards ... Hazard Perception," suggests that driving experience improves drivers, awareness ...
    ... In the May issue of Mayo Clinic ... pain management in cirrhotic patients. The physician experts reviewed ... no limits in the search to recommend a uniform ... patients. Cirrhosis is a substantial public health problem, ...
    Cached Medicine News:Health News:Affordable Implant Screening: Protect Against "Silent" Ruptures 2Health News:Talyst Reaches Major Milestone: 500 Implementations in Long-Term Care, Acute Care and Corrections 2Health News:Talyst Reaches Major Milestone: 500 Implementations in Long-Term Care, Acute Care and Corrections 3Health News:Prenatal Exposure to Chemicals Linked to Breast Cancer Risk 2Health News:Media arrangements for the International Congress on Obesity 2Health News:Elderly drivers' ability to detect hazards doesn't degrade with age according to Ben-Gurion U. 2Health News:Mayo Clinic Proceedings: Review of pain management practices for cirrhosis patients 2
    Preference Toric quarterly planned replacement lenses are durable, easy to handle and virtually maintenance free. Meeting the needs of those suffering from astigmatism, these soft contact lenses are ...
    ... fit for all astigmatic patients. Ideal ... who require excellent visual acuity and ... of disposable lenses; astigmatic spectacle wearers ... lenses; and spherically masked astigmatic patients ...
    C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
    ... Vitrasert implant is a device ... with Aids-related Cytomegalovirus (CMV) Retinitis. This ... CMV when compared with conventional intravenous ... embedded in a polymer-based system that ...
    Medicine Products: